Translate
Qiagen Nv
About
Qiagen Nv (NYSE:QGEN) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
Apr 16 2026
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
Apr 14 2026
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
Apr 1 2026
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
Mar 31 2026
Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
Financials
Revenue
$2.09 B
Market Cap
$8.46 B
P/E Ratio
20.11
EPS
2.04
Dividend Yield
0.65%